Background: Mucormycosis is a life-threatening,aggressive fungal infection that occursin COVID19 patients due to immune compromised state.Amphotericin B and surgical debridement are the treatment modalities. These patients can have a difficult airway owing to its inflammation, pose a challenge to the anaesthesiologist.Our aim was to compare Mc Grath MACVideo laryngoscope and direct laryngoscopeon the ease of intubation and haemodynamic response in patients with mucormycosis for debridement. Methods: This study was a randomised clinical trial on 100 patients with mucormycosis undergoing debridement surgery. Group A was intubated with Macinthosh laryngoscope and Group B with McGrathMAC Video laryngoscope. Primary outcome parameters were Cormack Lehane (CL) grade, time from laryngoscopy to successful intubation, number of attempts, use of airway adjuncts and any airway injury. Secondary outcome parameters were measurement of Heart Rate (HR), Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP),on arrival, before and after intubation, and at 1, 3, 5, and 10minutes after intubation. Result: Time from laryngoscopy to successful intubation was shorter in Group B (31.8 ±7.945) versus Group A (35.22±7.56) seconds. 8% patients hadairway injuries in Group A. No significant difference in the number of attempts,CormackLehane (CL) grade and use of airway adjuncts. Haemodynamic parameterswere better in Group B compared to Group A. Conclusion: Mc Grath MacVideo laryngoscopewas more acceptable with its glottic visualisation, shortest time for successful intubation with reduced aerosol exposure, and noairway traumawith better haemodynamic compared to direct laryngoscopefor intubation in patients with mucormycosis.